Sandra Sayão Maia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sandra Sayão Maia has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Guilherme Marinho Sampaio
Faculdade de Odontologia do Recife
7 shared publications - Luciano Barreto Silva
Faculdade de Odontologia do Recife
7 shared publications - Paulo Maurício Reis de Melo Júnior
Faculdade de Odontologia do Recife
6 shared publications - Gabriel Henrique Queiroz Oliveira
Faculdade de Odontologia do Recife
5 shared publications - Hadassa Fonsêca da Silva
Faculdade de Odontologia do Recife
5 shared publications - Rodolfo Scavuzzi Carneiro Cunha
Faculdade de Odontologia do Recife
5 shared publications
Latest Publications
- Open Access
- 9 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (4)
Bisphosphonates and their indication to prevent bone density loss in cancer therapy
Aim: To establish a protocol for patients medicated with bisphosphonates, through literature review, to avoid osteonecrosis and to provide professional guidance to accomplish the appropriate treatment. Methodology: On line searches were accomplished for the construction of this paper, which included as databases Web of Science, PUBMED Central, BVS/BIREME, Science Direct, The Cochrane Library and also PROSPERO. Results: The following characteristics were observed in the research of this protocol: Drugs with antireabsorption properties, RANK-L Inhibitor, Antiangiogenic agents, Clinical Manifestations, Drug-related risk factors, Local risk factors to be observed, Systemic and demographic risk factors, High risk factors considered. Conclusions: Bisphosphonates may be a helpful therapy for patients with organic consequences related to the therapy applied with them. Appropriate anamnesis and assessment of the systemic conditions for patients using them are mandatory requirements before their prescription.
- 9 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (4)
Open AccessBisphosphonates and their indication to prevent bone density loss in cancer therapy
Aim: To establish a protocol for patients medicated with bisphosphonates, through literature review, to avoid osteonecrosis and to provide professional guidance to accomplish the appropriate treatment. Methodology: On line searches were accomplished for the construction of this paper, which included as databases Web of Science, PUBMED Central, BVS/BIREME, Science Direct, The Cochrane Library and also PROSPERO. Results: The following characteristics were observed in the research of this protocol: Drugs with antireabsorption properties, RANK-L Inhibitor, Antiangiogenic agents, Clinical Manifestations, Drug-related risk factors, Local risk factors to be observed, Systemic and demographic risk factors, High risk factors considered. Conclusions: Bisphosphonates may be a helpful therapy for patients with organic consequences related to the therapy applied with them. Appropriate anamnesis and assessment of the systemic conditions for patients using them are mandatory requirements before their prescription.
- Open Access
- 1 January 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (1)
Mechanisms and substances involved in clastic activity of root resorptions – literature review
Aim: to research through literature review, the mechanisms involved in the establishment of root resorptions. Mediators such as interleukins, prostaglandins, nitric oxide and systemic calcium available were studied in this review. Methods: On line searches were accomplished by scrutinizing the database available from PUBMED Central, BVS/BIREME. Web of Science, Science Direct, Periodic Portal from CAPES, as well as The Cochrane Library and PROSPERO were also used. The inclusion criteria were articles that described osteoclastic activity involving the hard dental tissues (cement, dentin and enamel). The search acquired 35 articles and excluded other 30. The articles acquired ranged from 1976 up to 2017. Results: the results showed that the combination of the immunologic mediators researched above will be the determinant factors on the establishment of root resorptions. Conclusions: Prostaglandins, Interleukins as well as the systemic calcium available are some of the most important factors for the establishment of root resorptions. Their final outcome, however, depends directly on the quality of injury inflicted over the group of teeth, or single tooth, involved.
- 1 January 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (1)
Open AccessMechanisms and substances involved in clastic activity of root resorptions – literature review
Aim: to research through literature review, the mechanisms involved in the establishment of root resorptions. Mediators such as interleukins, prostaglandins, nitric oxide and systemic calcium available were studied in this review. Methods: On line searches were accomplished by scrutinizing the database available from PUBMED Central, BVS/BIREME. Web of Science, Science Direct, Periodic Portal from CAPES, as well as The Cochrane Library and PROSPERO were also used. The inclusion criteria were articles that described osteoclastic activity involving the hard dental tissues (cement, dentin and enamel). The search acquired 35 articles and excluded other 30. The articles acquired ranged from 1976 up to 2017. Results: the results showed that the combination of the immunologic mediators researched above will be the determinant factors on the establishment of root resorptions. Conclusions: Prostaglandins, Interleukins as well as the systemic calcium available are some of the most important factors for the establishment of root resorptions. Their final outcome, however, depends directly on the quality of injury inflicted over the group of teeth, or single tooth, involved.
- Open Access
- 12 September 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (12)
Azithromycin: characteristics and clinical indications for bacterial and virus infections, including SARS-CoV-2 infections
Objective: to accomplish a literature review to research the clinical characteristics of azythromycin, and its indications and associations for SARS-CoV-2 infections. Methodology: Electronic searches were carried out on PUBMED Central, BVS/BIREME, Web of Science and The Cochrane Library with the aid of key-words. Results: Azithromycin is a secure antibiotic belonging to the macrolide class, effective for a vast number of infections, especially respiratory diseases. It seems to have viral indirect activity due to its being capable of altering the cell machinery, including mitochondrias, for changing the normal functioning of mitochondrial ribosomes. Conclusion: It is uncertain whether azithromycin is eligible for the treatment of virus infections in general and especially for COVID-19. Its combination with hydroxychloroquine, however, should be better researched in order to answer if it can be applied as a clinical approach for this matter.
- 12 September 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (12)
Open AccessAzithromycin: characteristics and clinical indications for bacterial and virus infections, including SARS-CoV-2 infections
Objective: to accomplish a literature review to research the clinical characteristics of azythromycin, and its indications and associations for SARS-CoV-2 infections. Methodology: Electronic searches were carried out on PUBMED Central, BVS/BIREME, Web of Science and The Cochrane Library with the aid of key-words. Results: Azithromycin is a secure antibiotic belonging to the macrolide class, effective for a vast number of infections, especially respiratory diseases. It seems to have viral indirect activity due to its being capable of altering the cell machinery, including mitochondrias, for changing the normal functioning of mitochondrial ribosomes. Conclusion: It is uncertain whether azithromycin is eligible for the treatment of virus infections in general and especially for COVID-19. Its combination with hydroxychloroquine, however, should be better researched in order to answer if it can be applied as a clinical approach for this matter.
- Open Access
- 21 August 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (11)
Polimorfismo Genético do TNF-α e suas implicações na visualização do curso de patologias, incluindo doenças bucais
Objetivo: o objetivo deste trabalho foi explicar as implicações do perfil genético (polimorfismos do TNF-α na região 308) no desfecho de diferentes patologias; e explicar como esse perfil é obtido em laboratório. Metodologia: A técnica de salting out, segundo Miller et al. (1988) foi utilizado para explicar ao leitor como o perfil genético do TNF-α é obtido para prever o desfecho de patologias que são moduladas por essa citocina. Resultados: o produto da digestão amplificada dos genes do TNF-α foi obtido, fotografado e explicado ao leitor. Conclusões: o perfil genético pode ser útil como preditor de desfecho de diferentes patologias, para que médicos e dentistas possam escolher a melhor terapia para cada paciente.
- 21 August 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (11)
Open AccessPolimorfismo Genético do TNF-α e suas implicações na visualização do curso de patologias, incluindo doenças bucais
Objetivo: o objetivo deste trabalho foi explicar as implicações do perfil genético (polimorfismos do TNF-α na região 308) no desfecho de diferentes patologias; e explicar como esse perfil é obtido em laboratório. Metodologia: A técnica de salting out, segundo Miller et al. (1988) foi utilizado para explicar ao leitor como o perfil genético do TNF-α é obtido para prever o desfecho de patologias que são moduladas por essa citocina. Resultados: o produto da digestão amplificada dos genes do TNF-α foi obtido, fotografado e explicado ao leitor. Conclusões: o perfil genético pode ser útil como preditor de desfecho de diferentes patologias, para que médicos e dentistas possam escolher a melhor terapia para cada paciente.
- Open Access
- 3 August 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (10)
Antimalarial chloroquine indicated for viral infections: myth ou hope?
Aim: this article describes the use of chloroquine as an antimalarial agent with potential antivirotic indications for COVID-19 infections. Methods: On line searches and gray literature have been used in the construction of this articles, whose database include PUBMED Central, BVS/BIREME, Web of Science, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), Periodic Door (Portal de Periódicos da CAPES, The Cochrane Library and PROSPERO). Results: chloroquine and hydroxychloroquine has shown appropriate clinical reports when associated with the antibiotic Azithromycin. It has been authorized for the clinical treatment of grave acute forms of COVID infections by countries like Brazil and USA. Conclusions: Chloroquine seems to have potential antivirotic properties that may be useful in the treatment of the grave acute forms of COVID-19 associated with Azithromycin. Nevertheless, Its indication must include ECG monitoring due to the risk of cardiac QT prolongation able to cause sudden deaths.
- 3 August 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (10)
Open AccessAntimalarial chloroquine indicated for viral infections: myth ou hope?
Aim: this article describes the use of chloroquine as an antimalarial agent with potential antivirotic indications for COVID-19 infections. Methods: On line searches and gray literature have been used in the construction of this articles, whose database include PUBMED Central, BVS/BIREME, Web of Science, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), Periodic Door (Portal de Periódicos da CAPES, The Cochrane Library and PROSPERO). Results: chloroquine and hydroxychloroquine has shown appropriate clinical reports when associated with the antibiotic Azithromycin. It has been authorized for the clinical treatment of grave acute forms of COVID infections by countries like Brazil and USA. Conclusions: Chloroquine seems to have potential antivirotic properties that may be useful in the treatment of the grave acute forms of COVID-19 associated with Azithromycin. Nevertheless, Its indication must include ECG monitoring due to the risk of cardiac QT prolongation able to cause sudden deaths.
- Open Access
- 18 July 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (9)
Apice closure in Pulp Revascularization Therapy. Case report and literature review
Background: Endodontic Regenerative Procedures, especially pulp revascularization therapy, have become a real option for the treatment for immature permanent teeth with open apices. This sort of approach has saved many teeth that otherwise would have been extracted. The technique is simple and effective, and can be accomplished by any odontologist. Objective: This article aimed to make a literature review to give support for a case report of an Endodontic Regenerative Procedure of a twelve-year-old male patient with immature open apice of tooth 21. Methodology: Articles were researched concerning pulp revascularization to reach root end formation. On line searches were accomplished, whose database include BVS/BIREME, Web of Science, PUBMED Central, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), The Cochrane Library, and PROSPERO). Results: the articles researched showed that Endodontic Regenerative Procedures are efficient in stimulating root end formation. The case report described matched the results offered by the articles, showing an immature open apice tooth that had its root end completely formed after pulp revascularization therapy. Conclusion: Pulp revascularization therapy is an efficient and practical treatment for immature teeth with open apices.
- 18 July 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (9)
Open AccessApice closure in Pulp Revascularization Therapy. Case report and literature review
Background: Endodontic Regenerative Procedures, especially pulp revascularization therapy, have become a real option for the treatment for immature permanent teeth with open apices. This sort of approach has saved many teeth that otherwise would have been extracted. The technique is simple and effective, and can be accomplished by any odontologist. Objective: This article aimed to make a literature review to give support for a case report of an Endodontic Regenerative Procedure of a twelve-year-old male patient with immature open apice of tooth 21. Methodology: Articles were researched concerning pulp revascularization to reach root end formation. On line searches were accomplished, whose database include BVS/BIREME, Web of Science, PUBMED Central, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), The Cochrane Library, and PROSPERO). Results: the articles researched showed that Endodontic Regenerative Procedures are efficient in stimulating root end formation. The case report described matched the results offered by the articles, showing an immature open apice tooth that had its root end completely formed after pulp revascularization therapy. Conclusion: Pulp revascularization therapy is an efficient and practical treatment for immature teeth with open apices.
- Open Access
- 3 July 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (8)
The role of antiparasitc drugs and steroids in Covid-19 treatment
Background: COVID-19 has emerged as a pandemic that spread throughout the world in less than 6 months, leaving hundred thousand deaths behind. Surprisingly, old drug arsenal has now been applied as an option of treatment. Objective: The aim of this article was to accomplish a literature review concerning the antiparasitic chloroquine, ivermectin, nitazoxanide; as well as glucocorticoids as possible therapeutic agents to be applied in patients with COVID-19 in Brazilian hospitals. Methodology: clinical evidence of COVID-infected patients and literature consultation have been used for the construction of this article. On line searches and gray literature have also been consulted, whose database include PUBMED Central, BVS/BIREME, Web of Science, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), Periodic Door (Portal de Periódicos da CAPES, The Cochrane Library and PROSPERO). Results: chloroquine, ivermectin and nitazoxanide present antiviral characteristics to support their usage in phase 1 of COVID-19 symptoms. Glucocorticoids such as methylprednisolone and dexamethasone seem to be more efficient in patients with pulmonary symptoms such as those in phase 2B and 3. Conclusion: According to the articles raised in this review, antiparasitic agents are promising for patients with COVID-19 in the very beginning of the symptoms. Methylprednisolone and dexamethasone are best indicated for hospitalized patients with pulmonary commitment.
- 3 July 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (8)
Open AccessThe role of antiparasitc drugs and steroids in Covid-19 treatment
Background: COVID-19 has emerged as a pandemic that spread throughout the world in less than 6 months, leaving hundred thousand deaths behind. Surprisingly, old drug arsenal has now been applied as an option of treatment. Objective: The aim of this article was to accomplish a literature review concerning the antiparasitic chloroquine, ivermectin, nitazoxanide; as well as glucocorticoids as possible therapeutic agents to be applied in patients with COVID-19 in Brazilian hospitals. Methodology: clinical evidence of COVID-infected patients and literature consultation have been used for the construction of this article. On line searches and gray literature have also been consulted, whose database include PUBMED Central, BVS/BIREME, Web of Science, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), Periodic Door (Portal de Periódicos da CAPES, The Cochrane Library and PROSPERO). Results: chloroquine, ivermectin and nitazoxanide present antiviral characteristics to support their usage in phase 1 of COVID-19 symptoms. Glucocorticoids such as methylprednisolone and dexamethasone seem to be more efficient in patients with pulmonary symptoms such as those in phase 2B and 3. Conclusion: According to the articles raised in this review, antiparasitic agents are promising for patients with COVID-19 in the very beginning of the symptoms. Methylprednisolone and dexamethasone are best indicated for hospitalized patients with pulmonary commitment.